Rankings
▼
Calendar
XOMAP FY 2013 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena
XOMAP
XOMA Corporation
$311M
FY 2013 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$35M
+4.9% YoY
Gross Profit
$8M
22.8% margin
Operating Income
-$58M
-164.2% margin
Net Income
-$124M
-349.9% margin
EPS (Diluted)
$-10.95
Cash Flow
Operating Cash Flow
-$46M
Free Cash Flow
-$47M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$135M
Total Liabilities
$139M
Stockholders' Equity
-$4M
Cash & Equivalents
$102M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$35M
$34M
+4.9%
Gross Profit
$8M
$34M
-76.0%
Operating Income
-$58M
-$57M
-2.8%
Net Income
-$124M
-$71M
-74.6%
← FY 2012
All Quarters
FY 2014 →